Hosted on MSN5h
William Blair Initiates Coverage of Altimmune (ALT) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...
Hosted on MSN6h
William Blair Initiates Coverage of BioAge Labs (BIOA) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of BioAge Labs (NasdaqGS:BIOA) with a Market ...
Fintel on MSN11h
William Blair Initiates Coverage of Terns Pharmaceuticals (TERN) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of Terns Pharmaceuticals (NasdaqGS:TERN) with a ...
Fintel on MSN11h
William Blair Initiates Coverage of Structure Therapeutics Inc. - Depositary Receipt () (GPCR) with Outperform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of Structure Therapeutics Inc. - Depositary ...
Hosted on MSN8h
William Blair Initiates Coverage of Corbus Pharmaceuticals Holdings (CRBP) with Outperform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) ...
Is William Blair Small-Mid Cap Growth R6 (WSMRX) the Worst Performing Mutual Fund in 2024?
We recently published a list of 8 Worst Performing Mutual Funds in 2024. In this article, we are going to take a look at ...
What is William Blair’s Estimate for Arhaus FY2025 Earnings?
William Blair cut their FY2025 EPS estimates for Arhaus in a research note issued to investors on Wednesday, February 26th.
Research Analysts Set Expectations for EverQuote Q1 Earnings
Analysts at William Blair raised their Q1 2025 earnings per share (EPS) estimates for shares of EverQuote in a research ...
William Blair Sticks to Their Hold Rating for Altimmune (ALT)
In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Altimmune (ALT – Research Report). The company’s shares ...
William Blair Sticks to Its Buy Rating for Varonis Systems (VRNS)
William Blair analyst Jason Ader reiterated a Buy rating on Varonis Systems (VRNS – Research Report) today. The company’s shares opened today ...
William Blair Raises Earnings Estimates for HealthStream
Equities research analysts at William Blair lifted their Q1 2025 earnings estimates for HealthStream in a research note issued on Tuesday, February 25th. William Blair analyst R. Daniels now forecasts ...